As the clinical trial industry moves toward decentralisation, a new report by US Medical journal, JAMA oncology, has given an interesting insight into how remote monitoring works for Cancer Clinical Trials by analysing the effects of the COVID-19 pandemic on trial reporting.
Among its findings, the study observed that increased remote monitoring: Increases flexibility in trial participation and communication with physicians and may well be safe for patients going forward. However, it also may have implications for observing toxic effects from treatment, and this needs to be further examined.
A decline in Serious Adverse Event (e.g. serious deterioration of health or death) reporting was observed, likely due, not to telehealth, but other factors such as staffing shortages, heavy administration loads and frequent protocol changes.
It was felt that further studies were warranted to more closely observe if a link exists between remote participation and the level of SAE reporting.
COREX Logistics is a supply and logistics company with headquarters in Ireland, working with pharma and patients to facilitate improved healthcare worldwide.
Our expert international team works across an 80-country network, specialising in the EMEA region, providing the latest in clinical trial logistics technology and systems, cold-chain delivery, temperature-controlled transportation and storage services. From sourcing, procurement and customs clearance, to labelling, returns and destruction, we cover every link in the supply chain. We also run an established Named Patient Programme and provide Patient-Oriented services. With extensive knowledge and on-the-ground insight into our markets, we create innovative solutions with the ultimate goal of improving the lives of patients.